| Filed On | Filing |
|---|---|
| 12 Aug 2026 | Form 3: Sanofi, 10% owner |
| 06 Aug 2026 | Form 3: Foresite Capital Management V, Llc, 10% owner and 5 others |
| 06 Aug 2026 | Form 3: 5AM Ventures VI, L.p., 10% owner and 5 others |
| 06 Aug 2026 |
Form 3: Westlake BioPartners Fund I, L.p., 10% owner and 5 others
Holds 429,553 shares of Common Stock |
| 06 Aug 2026 |
Form 3: Smith Todd N, Director
No securities owned |
| 06 Aug 2026 | Form 3: Bonstein Sara, Director |
| 06 Aug 2026 | Form 3: Singla Neil, Chief Medical Officer |
| 06 Aug 2026 |
Form 3: Farzan Nima, Director
Holds 114,453 shares of Common Stock |
| 06 Aug 2026 | Form 3: Tananbaum James B., Director |
| 06 Aug 2026 |
Form 3: Seidenberg Beth C, Director
Holds 429,553 shares of Common Stock |
| 06 Aug 2026 | Form 3: Walbert Timothy P, Director |
| 06 Aug 2026 |
Form 3: Raidy Kevin, Director
No securities owned |
| 06 Aug 2026 | Form 3: Krishnamohan Neha, CFO and Chief Business Officer |
Loading...